Text Size

Urinary Catheter Exchange on Admission of Septic Elderly With Permanent Catheter Before Initiation of Antibiotics

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2007 by Shaare Zedek Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Shaare Zedek Medical Center
ClinicalTrials.gov Identifier:
NCT00503282
First received: July 17, 2007
Last updated: NA
Last verified: July 2007
History: No changes posted
  Purpose

In the era of emerging antibiotics resistant microbiology, we look for better outcome in the treatment of infections in the elderly.

We look for guidelines to manage an elderly who has a permanent urinary catheter, admitting to E.R. with Fever/Sepsis.

We assume that exchanging the permanent urinary catheter prior to the Urine Culture sample as well as for initiating antibiotic treatment will improve the outcome of the patients.It could help the day-to-day fight for the proper antibiotics treatment to avoid resistance.


Condition
Fever
Heart Rate
Blood Pressure
C-Reactive Protein
Erythrocyte Sedimentation Rate

Study Type: Observational
Study Design: Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Prospective

Resource links provided by NLM:

MedlinePlus related topics: Antibiotics Fever
U.S. FDA Resources

Further study details as provided by Shaare Zedek Medical Center:

Study Start Date: October 2007
Estimated Study Completion Date: October 2007
  Eligibility

Ages Eligible for Study:   65 Years to 95 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • >65 years
  • Permanent Urinary Catheter
  • FEVER or Septic State

Exclusion Criteria:

  • Supra-Pubic Aspiration Catheters
  • Septic Shock
  • I.V. Antibiotics Initiated before admission
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00503282

Contacts
Contact: Ron Ben - Itzhak, M.D. 972-544500187 ronbenitzhak@yahoo.com

Sponsors and Collaborators
Shaare Zedek Medical Center
Investigators
Principal Investigator: Ron Ben - Itzhak HEBREW UNIVERSITY, JERUSALEM
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00503282     History of Changes
Other Study ID Numbers: uc.ctil
Study First Received: July 17, 2007
Last Updated: July 17, 2007
Health Authority: Israel: Ethics Commission

ClinicalTrials.gov processed this record on May 22, 2013